Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use

Sexual behaviour among users of antiretroviral pre-exposure prophylaxis.

The pioneering trials of antiretroviral pre-exposure prophylaxis for HIV prevention have yielded a potent new strategy for the reduction of HIV incidence in atrisk populations. However, pre-exposure prophylaxis is inherently a combination approach: the intervention eff ect will depend not only on drug effi cacy, but also on behaviours of users and providers. Before the fi rst trial fi ndings em...

Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.

The global incidence of human immunodeficiency virus (HIV) infection has decreased by 15% over the past years, but is still too high. Despite current programs to reduce the incidence of HIV infection, further approaches are needed to limit this epidemic. Oral antiretroviral pre-exposure prophylaxis (PrEP) is currently one of the most discussed possible prevention methods. This literature study ...

Pre-exposure Prophylaxis (PrEP)

In 2012, the US Food and Drug Administration (FDA) approved Truvada to be used as PrEP by HIV negative people who are at high risk of sexually acquired HIV infection. The US Centre for Disease Control has since developed guidelines and recommended PrEP be used by people at high risk of HIV acquisition via sexual transmission or injection drug use (http://www.cdc.gov/hiv/prevention/research/prep/).

Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis.

BACKGROUND Scarce data are available to assess sexual behaviour of individuals using antiretroviral pre-exposure prophylaxis for HIV prevention. Increased sexual risk taking by individuals using effective HIV prevention strategies, like pre-exposure prophylaxis, could offset the benefits of HIV prevention. We studied whether the use of pre-exposure prophylaxis in HIV-uninfected men and women in...

Annotated Bibliography: Pre-Exposure Prophylaxis